Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- 6-K Current report (foreign)
- 99.1 Second Amendment to Exclusive License Agreement Between Labopharm Europe a Wholly-owned Subsidiary of the Registrant and Purdue Pharma Products L.P. Dated As of December 31, 2010.
- 99.2 Third Amending Agreement to the Distribution and License Agreement Between the Registrant and Paladin Labs Inc. Effective As of October 13, 2010.
- 99.3 Amended and Restated Manufacturing, Packaging and Supply Services Agreement Entered into Amongst the Registrant and Confab Laboratories Inc. Dated June 01, 2010
- 99.4 Amended and Restated Manufacturing, Packaging and Supply Services Agreement Entered into Amongst the Registrant and Confab Laboratories Inc. Dated June 01, 2010
Labopharm similar filings
- 29 Apr 11 Current report (foreign)
- 29 Apr 11 Labopharm to Host Conference Call
- 4 Apr 11 Labopharm Receives Notice from Nasdaq Regarding Minimum Market Value of Listed Securities
- 31 Mar 11 Second Amendment to Exclusive License Agreement
- 22 Mar 11 Current report (foreign)
- 22 Mar 11 Labopharm Announces Workforce Reduction and Appointment of New Cfo
- 14 Mar 11 Labopharm Announces Appointment of New President & Ceo
Filing view
External links
